Global Next-Generation Drug-Eluting Stent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 159153
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 121
  • list Medical Devices

Next-generation drug-eluting stent is advantageous as it offers improved deliverability by using materials like cobalt chromium, cobalt nickel, and cobalt alloy, this results in significant reduction in strut width, and enhance stent flexibility. In next-generation drug eluting stent, several drugs are coated in stents to address multiple restenosis pathways by altering drug release kinetics that mimics restenosis cascade. In addition, next-generation drug-eluting stent utilizes bioabsorbable polymers to reduce complications of late stent thrombosis, and bioresorbable drug-eluting scaffold plays a vital role in transforming coronary artery disease treatment.

Scope of the Report:

This report focuses on the Next-Generation Drug-Eluting Stent in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The market in North America is anticipated to show the largest market share for the next-generation drug-eluting stent, followed by Europe, owing to the high prevalence and incidence of coronary artery disease. In addition, presence sophisticated healthcare infrastructure, and well-trained healthcare professionals are also impelling the growth of next-generation drug eluting stent market. The market in Asia-Pacific region is estimated to grow at fastest CAGR over the forecast period owing to increasing investment from both public and private bodies and improving healthcare facilities. However, market in the Middle East & Africa shows the steady growth during the forecast period.

The worldwide market for Next-Generation Drug-Eluting Stent is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Abbott

Biosensors International

Medtronic

Sorin Group

SMT

Terumo

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Cobalt Chromium

Stainless Steel

Others

Market Segment by Applications, can be divided into

Hospitals

Clinics

Ambulatory Surgical Centers

There are 15 Chapters to deeply display the global Next-Generation Drug-Eluting Stent market.

Chapter 1, to describe Next-Generation Drug-Eluting Stent Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Next-Generation Drug-Eluting Stent, with sales, revenue, and price of Next-Generation Drug-Eluting Stent, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Next-Generation Drug-Eluting Stent, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Next-Generation Drug-Eluting Stent market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Next-Generation Drug-Eluting Stent sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Next-Generation Drug-Eluting Stent Introduction

1.2 Market Analysis by Type

1.2.1 Cobalt Chromium

1.2.2 Stainless Steel

1.2.3 Others

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Clinics

1.3.3 Ambulatory Surgical Centers

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Abbott

2.1.1 Business Overview

2.1.2 Next-Generation Drug-Eluting Stent Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Abbott Next-Generation Drug-Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Biosensors International

2.2.1 Business Overview

2.2.2 Next-Generation Drug-Eluting Stent Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Biosensors International Next-Generation Drug-Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Medtronic

2.3.1 Business Overview

2.3.2 Next-Generation Drug-Eluting Stent Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Medtronic Next-Generation Drug-Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Sorin Group

2.4.1 Business Overview

2.4.2 Next-Generation Drug-Eluting Stent Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Sorin Group Next-Generation Drug-Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 SMT

2.5.1 Business Overview

2.5.2 Next-Generation Drug-Eluting Stent Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 SMT Next-Generation Drug-Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Terumo

2.6.1 Business Overview

2.6.2 Next-Generation Drug-Eluting Stent Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Terumo Next-Generation Drug-Eluting Stent Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Next-Generation Drug-Eluting Stent Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Next-Generation Drug-Eluting Stent Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Next-Generation Drug-Eluting Stent Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Next-Generation Drug-Eluting Stent Manufacturer Market Share in 2017

3.3.2 Top 6 Next-Generation Drug-Eluting Stent Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Next-Generation Drug-Eluting Stent Market Analysis by Regions

4.1 Global Next-Generation Drug-Eluting Stent Sales, Revenue and Market Share by Regions

4.1.1 Global Next-Generation Drug-Eluting Stent Sales and Market Share by Regions (2013-2018)

4.1.2 Global Next-Generation Drug-Eluting Stent Revenue and Market Share by Regions (2013-2018)

4.2 North America Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

4.3 Europe Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

4.5 South America Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

5 North America Next-Generation Drug-Eluting Stent by Countries

5.1 North America Next-Generation Drug-Eluting Stent Sales, Revenue and Market Share by Countries

5.1.1 North America Next-Generation Drug-Eluting Stent Sales and Market Share by Countries (2013-2018)

5.1.2 North America Next-Generation Drug-Eluting Stent Revenue and Market Share by Countries (2013-2018)

5.2 United States Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

5.3 Canada Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

5.4 Mexico Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

6 Europe Next-Generation Drug-Eluting Stent by Countries

6.1 Europe Next-Generation Drug-Eluting Stent Sales, Revenue and Market Share by Countries

6.1.1 Europe Next-Generation Drug-Eluting Stent Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Next-Generation Drug-Eluting Stent Revenue and Market Share by Countries (2013-2018)

6.2 Germany Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

6.3 UK Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

6.4 France Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

6.5 Russia Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

6.6 Italy Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

7 Asia-Pacific Next-Generation Drug-Eluting Stent by Countries

7.1 Asia-Pacific Next-Generation Drug-Eluting Stent Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Next-Generation Drug-Eluting Stent Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Next-Generation Drug-Eluting Stent Revenue and Market Share by Countries (2013-2018)

7.2 China Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

7.3 Japan Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

7.4 Korea Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

7.5 India Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

8 South America Next-Generation Drug-Eluting Stent by Countries

8.1 South America Next-Generation Drug-Eluting Stent Sales, Revenue and Market Share by Countries

8.1.1 South America Next-Generation Drug-Eluting Stent Sales and Market Share by Countries (2013-2018)

8.1.2 South America Next-Generation Drug-Eluting Stent Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

8.3 Argentina Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

8.4 Colombia Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

9 Middle East and Africa Next-Generation Drug-Eluting Stent by Countries

9.1 Middle East and Africa Next-Generation Drug-Eluting Stent Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Next-Generation Drug-Eluting Stent Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Next-Generation Drug-Eluting Stent Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

9.3 UAE Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

9.4 Egypt Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

9.5 Nigeria Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

9.6 South Africa Next-Generation Drug-Eluting Stent Sales and Growth Rate (2013-2018)

10 Global Next-Generation Drug-Eluting Stent Market Segment by Type

10.1 Global Next-Generation Drug-Eluting Stent Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Next-Generation Drug-Eluting Stent Sales and Market Share by Type (2013-2018)

10.1.2 Global Next-Generation Drug-Eluting Stent Revenue and Market Share by Type (2013-2018)

10.2 Cobalt Chromium Sales Growth and Price

10.2.1 Global Cobalt Chromium Sales Growth (2013-2018)

10.2.2 Global Cobalt Chromium Price (2013-2018)

10.3 Stainless Steel Sales Growth and Price

10.3.1 Global Stainless Steel Sales Growth (2013-2018)

10.3.2 Global Stainless Steel Price (2013-2018)

10.4 Others Sales Growth and Price

10.4.1 Global Others Sales Growth (2013-2018)

10.4.2 Global Others Price (2013-2018)

11 Global Next-Generation Drug-Eluting Stent Market Segment by Application

11.1 Global Next-Generation Drug-Eluting Stent Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Clinics Sales Growth (2013-2018)

11.4 Ambulatory Surgical Centers Sales Growth (2013-2018)

12 Next-Generation Drug-Eluting Stent Market Forecast (2018-2023)

12.1 Global Next-Generation Drug-Eluting Stent Sales, Revenue and Growth Rate (2018-2023)

12.2 Next-Generation Drug-Eluting Stent Market Forecast by Regions (2018-2023)

12.2.1 North America Next-Generation Drug-Eluting Stent Market Forecast (2018-2023)

12.2.2 Europe Next-Generation Drug-Eluting Stent Market Forecast (2018-2023)

12.2.3 Asia-Pacific Next-Generation Drug-Eluting Stent Market Forecast (2018-2023)

12.2.4 South America Next-Generation Drug-Eluting Stent Market Forecast (2018-2023)

12.2.5 Middle East and Africa Next-Generation Drug-Eluting Stent Market Forecast (2018-2023)

12.3 Next-Generation Drug-Eluting Stent Market Forecast by Type (2018-2023)

12.3.1 Global Next-Generation Drug-Eluting Stent Sales Forecast by Type (2018-2023)

12.3.2 Global Next-Generation Drug-Eluting Stent Market Share Forecast by Type (2018-2023)

12.4 Next-Generation Drug-Eluting Stent Market Forecast by Application (2018-2023)

12.4.1 Global Next-Generation Drug-Eluting Stent Sales Forecast by Application (2018-2023)

12.4.2 Global Next-Generation Drug-Eluting Stent Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Next-Generation Drug-Eluting Stent Picture

Table Product Specifications of Next-Generation Drug-Eluting Stent

Figure Global Sales Market Share of Next-Generation Dru

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery